Endocrine

, Volume 48, Issue 2, pp 589–594 | Cite as

Association between TNM staging system and histopathological features in patients with papillary thyroid carcinoma

Original Article

Abstract

We aimed to assess the validity of the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system in patients with papillary thyroid carcinoma (PTC) by evaluating the relationships between clinicopathologic factors and TNM stage using histopathological specimens and electronic medical records. We enrolled 733 consecutive patients who had undergone thyroid surgery for PTC between 2010 and 2013. Clinical data were obtained from electronic medical records. TNM stages, multifocality, and bilaterality were analyzed after review of histopathological specimens by applying the AJCC TNM staging system. Multiple statistical analyses were performed to evaluate the correlation between the AJCC TNM staging system and the clinicopathologic factors. Of the 733 patients, there were T stage including T1a (46.9 %, 344/733), T1b (12.6 %, 92/733), T2 (2.0 %, 15/733), T3 (38.1 %, 279/733), T4a (0.4 %, 3/733), and T4b (0 %, 0/733), N stage including N0 (58.9 %, 432/733), N1a (24.3 %, 178/733), and N1b (16.8 %, 123/733), and multiplicity including multifocality (31.1 %, 228/733) and bilaterality (23.7 %, 174/733). There was a significant association between the PTC primary tumor size and T stage, N stage, multifocality, and bilaterality (p < 0.0001). Multifocality, bilaterality, and the presence of nodal metastasis were most frequently seen in patients with T3 stage (p < 0.0001). In multivariate logistic regression analyses, T and N stages were independent predictors of multiple PTCs. The PTC primary tumor size had a significant association with the T and N stages of the AJCC TNM staging system, and these factors were independent predictors of multifocality and bilaterality.

Keywords

Thyroid Papillary carcinoma T stage N stage AJCC 

References

  1. 1.
    N. Döbert, C. Menzel, S. Oeschger, F. Grünwald, Differentiated thyroid carcinoma: The new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients. Thyroid 14, 65–70 (2004)CrossRefPubMedGoogle Scholar
  2. 2.
    K.-C. Loh, F.S. Greenspan, L. Gee, T.R. Miller, P.P. Yeo, Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J. Clin. Endocrinol. Metab. 82, 3553–3562 (1997)CrossRefPubMedGoogle Scholar
  3. 3.
    N. Wada, H. Nakayama, N. Suganuma, Y. Masudo, Y. Rino, M. Masuda, T. Imada, Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J. Clin. Endocrinol. Metab. 92, 215–218 (2007)CrossRefPubMedGoogle Scholar
  4. 4.
    S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)CrossRefPubMedGoogle Scholar
  5. 5.
    M.J. Hayat, N. Howlader, M.E. Reichman, B.K. Edwards, Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12, 20–37 (2007)CrossRefPubMedGoogle Scholar
  6. 6.
    S.Y. Nam, J.H. Shin, B.-K. Han, E.Y. Ko, E.S. Ko, S.Y. Hahn, J.H. Chung, Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J. Clin. Endocrinol. Metab. 98, 1476–1482 (2013)CrossRefPubMedGoogle Scholar
  7. 7.
    L.J. DeGroot, E.L. Kaplan, M. McCormick, F.H. Straus, Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71, 414–424 (1990)CrossRefPubMedGoogle Scholar
  8. 8.
    Y. Ito, A. Miyauchi, M. Kihara, Y. Takamura, K. Kobayashi, A. Miya, Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study. Endocr. J. 59, 399–405 (2012)CrossRefPubMedGoogle Scholar
  9. 9.
    H. Ece, C.D. Devrim, T.A. Pelin, G. Ahmet, N.M. Ozgur, H. Mustafa, B. Mithat, Clinical experience of thyroid carcinoma: a study of 178 cases. Contemp. Oncol. (Pozn). 16, 218–222 (2012)PubMedCentralPubMedGoogle Scholar
  10. 10.
    D.W. Kim, J.S. Park, H.S. In, H.J. Choo, J.H. Ryu, S.J. Jung, Ultrasound-based diagnostic classification for solid and partially cystic thyroid nodules. AJNR Am. J. Neuroradiol. 32, 2136–2141 (2011)CrossRefPubMedGoogle Scholar
  11. 11.
    W.J. Moon, J.H. Baek, S.L. Jung, D.W. Kim, E.K. Kim, J.Y. Kim, J.Y. Kwak, J.H. Lee, J.H. Lee, Y.H. Lee, D.G. Na, J.S. Park, S.W. Park, Korean Society of Thyroid Radiology (KSThR). Korean Society of Radiology, Ultrasonography and ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol. 12, 1–14 (2011)CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    F. Iida, M. Yonekura, M. Miyakawa, Study of intraglandular dissemination of thyroid cancer. Cancer 24, 764–771 (1969)CrossRefPubMedGoogle Scholar
  13. 13.
    R. Katoh, J. Sasaki, H. Kurihara, K. Suzuki, Y. Iida, A. Kawaoi, Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70, 1585–1590 (1992)CrossRefPubMedGoogle Scholar
  14. 14.
    F.L. Greene, TNM: our language of cancer. CA Cancer J. Clin. 54, 129–130 (2004)CrossRefPubMedGoogle Scholar
  15. 15.
    J.D. Brierley, T. Panzarella, R.W. Tsang, M.K. Gospodarowicz, B. O’Sullivan, A comparison of different staging systems predictability of patient outcome. Cancer 79, 2414–2423 (1997)CrossRefPubMedGoogle Scholar
  16. 16.
    M. Bramley, B. Harrison, Papillary microcarcinoma of the thyroid gland. Br. J. Surg. 83, 1674–1683 (1996)CrossRefPubMedGoogle Scholar
  17. 17.
    Y. Ito, M. Kihara, M. Hirokawa, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Validity of 6(th) edition of UICC TNM classification system for medullary thyroid carcinoma: a proposal for intraoperative evaluation of T category. Endocr. J. 59, 407–416 (2012)CrossRefPubMedGoogle Scholar
  18. 18.
    Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J. Surg. 30, 780–786 (2006)CrossRefPubMedGoogle Scholar
  19. 19.
    G. Conzo, N. Avenia, G. Bellastella, G. Candela, A. de Bellis, K. Esposito, D. Rasquali, A. Polistena, L. Santini, A.A. Sinisi, The role of surgery in the current management of differentiated thyroid cancer. Endocrine (2014). doi:10.1007/s12020-014-0251-9 PubMedGoogle Scholar
  20. 20.
    J.S. Choi, E.K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.1007/s12020-014-0293-z Google Scholar
  21. 21.
    C.Y. Lo, K.Y. Lam, Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC tumor staging system: stage migration and predictability. Ann. Surg. Oncol. 14, 1551–1559 (2007)CrossRefPubMedGoogle Scholar
  22. 22.
    R.M. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein, M. Gonen, M. Brokhin, G. Omry, J.A. Fagin, A. Shaha, Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 12, 1341–1349 (2010)CrossRefGoogle Scholar
  23. 23.
    C. Durante, T. Montesano, M. Torlontano, M. Attard, F. Monzani, S. Tumino, G. Costante, D. Meringolo, R. Bruno, F. Trulli, M. Massa, A. Maniglia, R. D’Apollo, L. Giacomelli, G. Ronga, S. Filetti, PTC Study Group: papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J. Clin. Endocrinol Metab. 98, 636–642 (2013)CrossRefPubMedGoogle Scholar
  24. 24.
    D. Mankarios, P. Baade, P. Youl, R.H. Mortimer, A.A. Onitilo, A. Russell, S.A. Doi, Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. Endocrine 46, 300–308 (2014)CrossRefPubMedGoogle Scholar
  25. 25.
    S.I. Sherman, J.D. Brierley, M. Sperling, K.B. Ain, S.T. Bigos, D.S. Cooper, B.R. Haugen, M. Ho, I. Klein, P.W. Ladenson, J. Robbins, D.S. Ross, B. Specker, T. Taylor, H.R. Maxon 3rd, Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83, 1012–1021 (1998)CrossRefPubMedGoogle Scholar
  26. 26.
    P.W. Grigsby, R.M. Reddy, J.F. Moley, B.L. Hall, Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 140, 1043–1049 (2006)CrossRefPubMedGoogle Scholar
  27. 27.
    H.J. Kim, S.Y. Sohn, H.W. Jang, S.W. Kim, J.H. Chung, Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J. Surg. 37, 376–384 (2013)CrossRefPubMedGoogle Scholar
  28. 28.
    S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D.M. Hartl, J.M. Bidart, J.P. Travagli, M. Schlumberger, Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J. Clin. Endocrinol. Metab. 90, 5723–5729 (2005)CrossRefPubMedGoogle Scholar
  29. 29.
    W. Zhao, X. Teng, X. Chen, Z. Li, X. Yu, T.J. Fahey III, Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann. Surg. Oncol. 19, 31–36 (2012)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Radiology, Haeundae Paik HospitalInje University College of MedicineBusanSouth Korea
  2. 2.Department of Radiology, Busan Paik HospitalInje University College of MedicineBusanSouth Korea

Personalised recommendations